Skip to main content
Premium Trial:

Request an Annual Quote

BioForce Nanosciences, French Researchers to Collaborate on Neural Cell-based Assays

NEW YORK (GenomeWeb News) – BioForce Nanosciences today said that it will collaborate with researchers from the University Pierre & Marie Curie and the Centre National de Recherche Scientifique to develop technologies, protocols, and products related to neural cell-based assays.
The assays will be created using BioForce’s Nano eNabler molecular printer, which will allow scientists to study the structure, function, and microenvironments of neural cells. The Ames, Iowa-based firm said that neural cell-based assays hold “great promise” for evaluating the potential of new drug compounds for treating neurodegenerative diseases and neural trauma.
"This novel molecular microprinting device appears to be a very useful and flexible technology to bring new insights into the cellular response processes, such as proliferation, apoptosis, morphogenesis, and differentiation,” Fatiha Nothias, principal investigator at UPMC, said in a statement.
Financial and other terms of the collaboration were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more